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Background: Renal scintigraphy using 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) is widely used for the
assessment of renal function in humans. However, the application of this method to animal models of renal disease
is currently limited, especially in rodents. Here, we have applied 99mTc-MAG3 renal scintigraphy to a mouse model
of unilateral ureteral obstruction (UUO) and evaluated its utility in studying obstructive renal disease.
Methods: UUO mice were generated by complete ligation of the left ureter. Sham-operated mice were used as a
control. Renal function was investigated on days 0, 1, 3, and 6 post-surgery using dynamic planar imaging of
99mTc-MAG3 activity following retro-orbital injection. Time-activity curves (TACs) were produced for individual
kidneys and renal function was assessed by 1) the slope of initial 99mTc-MAG3 uptake (SIU), which is related to renal
perfusion; 2) peak activity; and 3) the time-to-peak (TTP). The parameters of tubular excretion were not evaluated
in this study as 99mTc-MAG3 is not excreted from UUO kidneys.
Results: Compared to sham-operated mice, SIU was remarkably (>60%) reduced in UUO kidneys at day 1 post
surgery and the TACs plateaued, indicating that 99mTc-MAG3 is not excreted in these kidneys. The plateau activity in
UUO kidneys was relatively low (~40% of sham kidney’s peak activity) as early as day1 post surgery, demonstrating
that uptake of 99mTc-MAG3 is rapidly reduced in UUO kidneys. The time to plateau in UUO kidneys exceeded
200 sec, suggesting that 99mTc-MAG3 is slowly up-taken in these kidneys. These changes advanced as the disease
progressed. SIU, peak activity and TTPs were minimally changed in contra-lateral kidneys during the study period.
Conclusions: Our data demonstrate that renal uptake of 99mTc-MAG3 is remarkably and rapidly reduced in UUO
kidneys, while the changes are minimal in contra-lateral kidneys. The parametric analysis of TACs suggested that
renal perfusion as well as tubular uptake is reduced in UUO kidneys. This imaging technique should allow
non-invasive assessments of UUO renal injury and enable a more rapid interrogation of novel therapeutic agents
and protocols.
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There is considerable interest and potential value in
making available imaging methods that permit non-
invasive assessments of renal function in animals. Renal
scintigraphy or renograms using 99mTc-mercaptoacetyl-
triglycine (99mTc-MAG3) is widely used for the assess-
ment of renal function in humans, especially for the
evaluation of postoperative complications in renal trans-
plant recipients [1]. This radiotracer is extracted from
the kidneys with high efficiency through secretion from
proximal tubules [2,3]. The time-activity curves (TACs)
of 99mTc-MAG3 renograms, which are produced by
dynamic scan, enable the real-time and quantitative
evaluation of multiple features of renal function, while
the renography created by static scan provides spatial
information about 99mTc-MAG3 kinetics and kidney
morphology. The first phase of the TACs, which rises as
99mTc-MAG3 flows into renal tissue, can be used as an
indicator of renal perfusion and tubular uptake, while
the descending phase provides an assessment of tubular
excretion [4,5] (Additional file 1). Thus, the measure-
ment of intrarenal 99mTc-MAG3 kinetics provides a
minimally invasive, simple, and quantitative test of renal
function, which does not require blood or urine sam-
pling. Given these features, 99mTc-MAG3 renography
could serve as a useful tool for the repetitive and longi-
tudinal assessment of renal function in pre-clinical ani-
mal models of renal disease. However, the application of
this method to animal models of renal disease is cur-
rently limited, especially in rodents. In mice, only a few
studies have employed it to assess ischemia and reperfu-
sion renal injury [5,6]. Also, quantitative analysis and
longitudinal investigation of 99mTc-MAG3 renograms
have not been carried out in animals with unilateral ur-
eteral obstruction (UUO).
Obstructive nephropathy is a major cause of renal im-
pairment in infants and children [7]. Over the past few
decades, the cellular and molecular events involved in
obstructive renal injury have been elucidated by surgical
ligation of a ureter (known as UUO) in postnatal
and adult animals [8,9]. These include tubular and myo-
fibroblast proliferation, interstitial inflammation, tubular
atrophy/apoptosis, interstitial fibrosis, and renin-
angiotensin and TGFβ activation. Further, the UUO
model recapitulates all of the key features of renal fibro-
sis, a hallmark of progressive renal disease; therefore, the
model is widely used for the research of renal fibrogenic
response [9,10]. However, disorders of renal function
during the course of the UUO model are incompletely
understood, as the measurements of renal function in a
single kidney are methodologically limited. Thus, the
purpose of the present study was to investigate the use
of dynamic 99mTc-MAG3 imaging for the assessment of
renal function in a mouse UUO model. Our datademonstrate that renal uptake of 99mTc-MAG3 is re-
markably and rapidly reduced in UUO kidneys as early
as day 1 post-surgery, while it is minimally changed in
contralateral kidneys. Further, the parametric analysis of
TACs suggested that renal perfusion as well as tubular
uptake is reduced in UUO kidneys. This imaging tech-
nique should allow non-invasive assessments of UUO
renal injury and enable a more rapid interrogation of
novel therapeutic agents and protocols.
Methods
Animals
Male C57BL/6N mice, aged 6 weeks, were purchased from
Harlan Laboratories (Indianapolis, IN). Animals were fed
a standard diet and allowed free access to water. All ani-
mal procedures were conducted in accordance with insti-
tutional guidelines and approved by the Vanderbilt
University Institution of Animal Care and Use Committee.
Unilateral ureteral obstruction
Mice were anesthetized with 2% isoflurane and the left
kidney was exposed through the site of the left flank in-
cision. The ureter was obstructed completely near the
renal pelvis using a 4–0 silk tie suture at two points.
Sham-operated mice underwent the same surgical pro-
cedure except for the ureter ligation. The mice were
imaged at 0 (3 hours), 1, 3, and 6 days after surgery.
99mTc-MAG3 Renal scintigraphy
Mice were anesthetized with 1.5%/98.5% isoflurane/oxygen
mixture and two mice at a time were placed directly on
top of a parallel-hole collimator positioned over one of the
four camera heads of a NanoSPECT/CT (Bioscan, Wash-
ington, DC). The NanoSPECT was set up in single-camera
planar-dynamic mode. A 40 min dynamic acquisition was
initiated simultaneously with retro-orbital injection of ~37
MBq/0.2 mL of 99mTc-MAG3 (obtained from VUMC
Radiopharmacy, Vanderbilt University). The 40 min dy-
namic planar acquisition was divided into 240 frames yield-
ing a temporal resolution of 10 sec. Two-dimensional
images were collected in a 256 x 256 matrix with a pixel
size of 0.29 mm x 0.29 mm. For static imaging, three di-
mensional images were collected in a 176 x 176 x 112
matrix with a pixel size of 0.2 mm x 0.2 mm x 0.2 mm
through a 40-min scan (a temporal resolution of 40 min),
producing high resolution imaging data. In a comparison
study (retro-orbital vs. intravenous injections), 99mTc-
MAG3 was injected into mice via jugular catheter. Jugular
vein catheterization was carried out as described [11].
Image analysis
The planar images were imported into the medical
image viewer software Amide [12]. Two-dimensional el-
lipsoidal shaped regions of interest (ROIs) were drawn
Figure 1 Renal structure and histopathology in UUO mice. (A) Representative T1- and T2-weighted coronal MRI images of UUO kidney at day
0, 1, 3 and 6 post obstruction. Renal pelvic space (asterisks) is progressively expanded in the obstructed kidney, and renal medulla (outlined with
dotted lines), especially inner medulla and papilla, is remarkably decreased as the disease progresses. Arrows indicate urine. C, cortex; OM, outer
medulla (inner stripe); IM, inner medulla; P, papilla. (B) Representative histological sections of mouse kidneys subjected to unilateral ureteral
obstruction. Tubulointerstitial region increases markedly over 6 days in UUO kidneys, as indicated by destructive morphology of renal tubules
(asterisks) and interstitial fibrosis (arrows). Bar=100 μm. Masson trichrome stain.
Figure 2 Representative time-activity curves (TACs) of
99mTc-MAG3 dynamic renal scintigraphy in normal mice.
99mTc-MAG3 was retro-orbitally injected to mice and the TACs were
established as described in “Materials and Methods”. The slope of
initial uptake (SIU) which rises linearly, peak activity, and the
time-to-peak (TTP) were determined and used as parameters of
renal 99mTc-MAG3 uptake.
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the mouse. The radioactivity within the ROIs was
extracted for each frame and normalized to the injected
dose for each animal, dividing image voxel values by the
actual injected dose as measured in a CRC-15W dose
calibrator (Capintec, Ramsey, NJ), to establish the TACs
over the entire duration of the scan. The data were
expressed as normalized image value (NIV). The slope
of initial linear uptake (from 10s to 40s)(SIU) in units of
1/s, peak activity in units of NIV, and the time to peak
or plateau (TTP or TTPt) in units of seconds were com-
puted from the renogram of each kidney [5,13]. [Note:
Since the TACs of UUO kidneys plateau and do not
peak, we measured the plateau activity and the time-to-
plateau for these kidneys.]
Magnetic resonance imaging (MRI)
Structural changes in UUO kidneys were assessed by MRI
studies on a Varian 7T horizontal bore imaging system
(Lexington, MA). Anesthesia was induced and maintained
Figure 3 Comparison of TACs established by intravenous and retro-orbital 99mTc-MAG3 injections. (A) Mean TACs established by
intravenous (n=7) and retro-orbital (n=12) 99mTc-MAG3 injections. For intravenous injection, 99mTc-MAG3 was injected via jugular vein catheter.
Values are means ± SE. (B) Comparison of the parameters (SIU, peak activity, and TTP) extracted from the TACs generated by intravenous and
retro-orbital 99mTc-MAG3 injections. No significant difference was found between the two procedures.
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body temperature of 37°C was maintained using heated
air flow. Animals were placed in a prone position and
imaged using a birdcage 25-mm inner diameter radiofre-
quency (RF) coil. All imaging protocols were based on a
field-of-view of 25.6 x 25.6 mm2. A multi-slice gradient
echo imaging sequence [repetition time (TR) =25ms; echo
time (TE) = 2.5ms; 128 x 128 matrix; 2-mm slice thick-
ness] was used to acquire 3-plane multi-slice images for
proper positioning and slice selection. A coherent gradient
echo sequence was used for T1-weighted imaging (TR =
45 ms; TE = 2.25 ms; flip angle = 35°; number of excita-
tions (NEX) = 81). T2 contrast was achieved with the use
of a fast spin-echo (FSE) sequence (TR = 2000ms; effective
TE = 48 ms; RARE-factor 8, 256 x 256 matrix; 0.5-mm
slice thickness).
Histological assessment
Kidneys were removed from euthanized mice, fixed over-
night in 10% buffered formalin, and paraffin tissue sec-
tions were stained with Masson trichrome using standard
procedures.
Statistical analysis
One-way ANOVA followed by a Dunnett post test was
carried out to compare the mean values in different days
and groups. A two-tailed paired t-test was carried out
for comparisons between obstructed and unobstructed(contralateral) kidneys. Data were expressed as means ±
SEM. The derived p-values were considered statistically
significant when less than 0.05.
Results
In the present study, we assessed renal function in UUO
mice using 99mTc-MAG3 dynamic renal scintigraphy.
Renal uptake of 99mTc-MAG3 was assessed by paramet-
ric analysis of TACs. Since 99mTc-MAG3 is not excreted
from UUO kidneys, parametric analysis of 99mTc-MAG3
excretion was not performed in this study.
Renal structure and histopathology in UUO mice
First, we confirmed generation and severity of UUO
model by MRI and histological investigation. Figure 1
shows representative T1- and T2-weighted MR images of
a UUO mouse at 0, 1, 3 and 6 days post-surgery. The renal
pelvic space was gradually expanded in obstructed kidneys
as early as 1 day post ureteral ligation and the components
of renal medulla, especially inner medulla and papilla,
were remarkably decreased as the disease progressed. Re-
duction of renal cortex was also observed at day 3 and day
6 post obstruction. Histological investigation displayed
typical patterns of UUO renal disease, including tubular
dilatation, flattening and atrophy, and expansion of inter-
stitial area with extracellular matrix accumulation and in-
filtration of inflammatory cells (Figure 1, bottom panels).
Tubulointerstitial region progressed markedly over 6 days
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were not observed in contralateral kidneys and sham-
operated mouse kidneys (data not shown).
Parametric analysis of TACs and comparison of
intravenous and retro-orbital 99mTc-MAG3 injections
Renal function was assessed in UUO kidneys based on
the TACs and their parametric analysis. Three para-
meters were measured for individual kidneys: 1) the
slope of initial linear uptake (SIU, 1/s), which is related
to renal perfusion; 2) the peak activity (NIV); and 3) the
time-to-peak or plateau (TTP or TTPt, sec) (Figure 2).
Radiotracers are usually administrated via the tail vein in
rodents. However, repeated injections are difficult as the
procedure frequently causes soft tissue extravasations
and tail scars, preventing subsequent injections. Repeat-
able and proper intravenous injections are fundamental
for the longitudinal and quantitative analysis of 99mTc-
MAG3 renal scintigraphy. Therefore, we first compared
retro-orbital and intravenous injections, given the facts
that the former is much easier to accomplish at mul-
tiple time points and that retro-orbital injection was
recently shown to be an effective route of radiotracerFigure 4 TACs of 99mTc-MAG3 dynamic renal scintigraphy in UUO mic
(E) Sham operation day 0, (F) Sham operation day 6. Values are means ± Sadministration during PET studies in mice [14]. As
shown in Figure 3A, the TACs of 99mTc-MAG3 renal
scintigraphy obtained from retro-orbital injections were
comparable to those from intravenous injections via
jugular vein catheter. There was no significant difference
in the SIU, peak activity, and TTP parameters between
these two procedures (Figure 3B). In addition, a com-
parative study using UUO day 1 mice also showed no
difference between these two administration routes (data
not shown). These results demonstrate that retro-orbital
injection can be used for 99mTc-MAG3 renal scintig-
raphy in mice. Therefore, in this study we assessed renal
function in UUO mice using retro-orbital injections of
99mTc-MAG3.
Assessment of renal function in UUO mice using
99mTc-MAG3 dynamic scintigraphy
Renal scintigraphy was carried out in UUO and sham-
operated mice at 0 (3 hours), 1, 3, and 6 days after sur-
gery. Non-surgery mice were also imaged as a control.
Figure 4 A-D shows TACs of UUO kidneys at each time
point. As shown in Figure 4B, renal uptake of 99mTc-
MAG3 was remarkably reduced in UUO kidneys as earlye. (A) UUO day 0, (B) UUO day 1, (C) UUO day 3, (D) UUO day 6,
E. The numbers of mice are described in Table 1.
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ity throughout the TACs, and it was further decreased as
the disease progressed (Figure 4C and 4D). The TACs in
UUO kidneys plateaued over time, indicating that
99mTc-MAG3 is not excreted in these kidneys. Profound
reduction of 99mTc-MAG3 uptake was also demon-
strated in UUO kidney by the time interval images of
renal scintigraphy (Figure 5). Further, static renal scintig-
raphy demonstrated that excretion of 99mTc-MAG3 to
renal pelvis is highly limited in UUO kidneys, even at
day 0 (3 hrs) post surgery (Figure 6); the finding indi-
cates that TACs of UUO kidneys mostly demonstrate
the deposition of 99mTc-MAG3 in renal parenchyma.
The contralateral kidneys in UUO mice (Figure 4 A-D)
and kidneys in sham-operated mice (Figure 4E and 4F)
showed similar TACs. Table 1 and Figure 7 show the
parametric analysis of 99mTc-MAG3 renal scintigraphy
based on TACs obtained from UUO and sham operation
mice at day 0, 1, 3, and 6 post surgery. The results of
statistical analysis are shown in Table 2. As compared to
sham-operated kidneys, SIU was remarkably (> 60%)
decreased in UUO kidneys as early as day 1 post ob-
struction, while contralateral kidneys showed SIU values
comparable to those in sham-operated kidneys
(Figure 7A). It is noteworthy that the slope of theFigure 5 Representative time-interval images of 99mTc-MAG3 dynami
Uptake of the tracer is remarkably reduced in UUO kidney. A) 0–1 min, B) 1
35–40 min. R, right; L, left; CL, contralateral kidney.ascending phase (50s to peak, denoted Phase 2), which
follows the initial linear uptake of 99mTc-MAG3 (10s to
40s, denoted Phase 1), was progressively increased in
contralateral kidneys, though it was not statistically signifi-
cant against day 0 or sham operation kidneys (Figure 8).
The plateau activity of TACs was also remarkably (~65%)
reduced in UUO kidneys as early as day 1 post obstruction
and it declined further as the disease progressed, while the
peak activity in contralateral kidneys was comparable to
those in sham-operated kidneys during the study period
(Figure 7B). Further, the time-to-plateau (TTPt) in UUO
kidneys largely exceeded the time-to-peak (TTP) values in
sham-operated or contralateral kidneys (Figure 7C), sug-
gesting that 99mTc-MAG3 is slowly up-taken in UUO kid-
neys. The TTP was unaltered in contralateral kidneys as
compared with sham operation kidneys, yet contralateral
kidneys at UUO day 6 showed significantly shorter TTP
than at UUO day 0, 1, and 3 (Figure 7C, Table 2). There
was no significant difference in the peak:10min ratio, an
indicator of tubular excretion rate [5,6], between contra-
lateral kidneys and sham-operated kidneys, though
contralateral kidneys showed lower peak:10min ratios at
day 0 and day 1, perhaps due to intravascular fluid shifts
during surgical procedure (data not shown). No difference
was observed in SIU, peak activity, TTP, and peak:10minc renal scintigraphy in UUO mice at 6 days post obstruction.
–2 min, C) 2–6 min, D) 6–15 min, E) 15–25 min, F) 25–35 min, and G)
Figure 6 Static 99mTc-MAG3 imaging of UUO mice kidneys. A) Static SPECT images (a 40-min acquisition) were obtained from UUO day 6
and sham-operated mice kidneys after retro-orbital injection of 99mTc-MAG3. The excretion of 99mTc-MAG3 to renal pelvis is not observed in UUO
day 6 kidney, while 99mTc-MAG3 gets into renal pelvis in sham-operated kidney during a 40 min scan. B) Similar findings were observed in UUO
day 0 and day 1 kidneys, while 99mTc-MAG3 was excreted to renal pelvis (arrows) in contralateral kidneys (CL). Representative images are shown.
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neys and between sham-operated and contralateral kid-
neys in sham mice.
Discussion
In the present study, we have applied 99mTc-MAG3 renal
scintigraphy to a mouse model of obstructive nephropathyTable 1 Parameters extracted from the TACs of 99m Tc-MAG3
Kidney n Peak or plateau* ac
Normal (non-surgery) 12 4.63 ± 0.20
UUO day 0 6 4.48 ± 0.19
UUO day 1 5 1.98 ± 0.20
UUO day 3 6 1.45 ± 0.10
UUO day 6 8 1.06 ± 0.09
Contralateral day 0 6 4.22 ± 0.26
Contralateral day 1 5 4.56 ± 0.36
Contralateral day 3 6 4.43 ± 0.35
Contralateral day 6 8 4.43 ± 0.28
Sham day 0 7 4.19 ± 0.33
Sham day 1 8 4.95 ± 0.40
Sham day 3 5 4.16 ± 0.18
Sham day 6 4 4.35 ± 0.49
Values are means ± SE. * Plateau activity and the time-to-plateau (TTPt) were measuand non-invasively evaluated renal function over 6 days
post obstruction. Our results demonstrate that renal up-
take of 99mTc-MAG3 is rapidly reduced by ureteral
ligation, while it is minimally changed in the contralateral
kidney. This work provides the first non-invasive evalu-
ation of longitudinal changes in renal function in UUO
animals. Further, our data demonstrate that retro-orbitaldynamic renal scintigraphy
tivity (NIV) SIU (activity/s) TTP, TTPt* (s)
0.129 ± 0.008 98 ± 5
0.090 ± 0.010 437 ± 35
0.051 ± 0.014 213 ± 38
0.055 ± 0.011 258 ± 46
0.041 ± 0.008 138 ± 33
0.139 ± 0.015 93 ± 5
0.122 ± 0.012 91 ± 9
0.135 ± 0.018 95 ± 14
0.136 ± 0.014 83 ± 5
0.131 ± 0.032 101 ± 10
0.158 ± 0.023 108 ±18
0.125 ± 0.009 87 ± 17
0.149 ± 0.027 85 ± 7
red in UUO kidneys.
Figure 7 Parametric analysis of 99mTc-MAG3 dynamic renal
scintigraphy obtained from UUO, sham-operated, and
non-surgery (control) mice. Values are means ± SE. The numbers
of mice are described in Table 1. Note: The time-to-plateau (TTPt)
was measured in UUO kidneys.




UUO vs. Sham days 1, 3, 6
Contralateral vs. Sham none
UUO vs. Contralateral days 1, 3, 6
UUO vs. UUO day 0 vs. days 1, 3 & 6; day 1 vs.
Contralateral vs. Contralateral none
* As TACs of UUO kidney did not peak, statistical test was not applied to this sectio
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in mice.
A substantial reduction of SIU was observed in UUO
kidney. Several studies have demonstrated acute reduction
in renal blood flow (RBF) in UUO animals. Vaughan et al.
measured RBF in a dog UUO model using a flow probe
placed in renal artery and showed that RBF is transiently
increased in UUO kidney at 0–1.5 hrs post obstruction,
followed by a progressive decline [15,16]. In their study,
RBF was decreased by ~50% in UUO kidney within 18 hrs
post obstruction, while changes in RBF were not observed
in contralateral kidney. Similar results have been demon-
strated by other studies measuring renal arterial blood
flow in rat or dog UUO models [17-19]. Thus, the changes
of SIU are consistent with these previous results of RBF
measurements on renal artery in experimental UUO kid-
neys, suggesting that the decreases in SIU may largely re-
sult from reduced renal perfusion. It is of note that the
plateau activity is also substantially reduced in UUO
mouse kidney at day 1 post obstruction, whereas a reduc-
tion of vessel density is not observed at this time point;
the finding suggests that the capacity of 99mTc-MAG3 up-
take is also reduced in UUO day 1 kidney, perhaps due to
tubular cell injury. This may also be the reason why the
time-to-plateau is shortened in UUO kidney at day 1 post
obstruction. Thus, our results suggest that reduced renal
perfusion and tubular injury causes remarkable reduction
of 99mTc-MAG3 uptake in UUO kidney and that these
parameters may be used for assessing the severity of ob-
structive renal disease.
In contrast to the obstructed kidney, the changes in SIU,
peak activity, and TTP were not observed in contralateral
kidney, even though the obstructed kidney was function-
ally dead. Given the fact that unilateral nephrectomy
increases renal arterial blood flow by ~50% in two days
[20,21], it seems that the systemic factors produced by the
UUO kidney and/or the presence of renal blood flow in
the obstructed kidney attenuate adaptive responses in the
contralateral kidney. It is of note that the slope of the
ascending phase after linear uptake of 99mTc-MAG3 was
increased in contralateral kidneys. Although the mechan-
ism of this is currently unknown, the finding suggests thattralateral, and sham-operated kidneys on all days post
P < 0.05
SIU TTP
days 1, 3, 6 N/A*
none none
days 0, 1, 3, 6 N/A*
day 6 day 0 vs. day 6 day 0 vs. days 1, 3 & 6
none day 6 vs. days 0, 1, & 3
n.
Figure 8 Slope of ascending phase is increased in contralateral kidneys after UUO surgery. A) Graphical depiction of ascending phase
window selection in contralateral kidneys at 0 and 6 days post ureteral obstruction. B) The slope of ascending phase (from 50s to peak) was
measured for the contralateral kidneys in UUO and sham-operated mice. Values are means ± SE. The numbers of mice are described in Table 1.
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in contralateral kidneys.
In dog and rat UUO models, it has been suggested that
increased renal endothelin-1 production [18], enhanced
renin-angiotensin system (RAS) [22], and insufficient
nitric oxide synthesis [15,16,23] cause vasoconstriction in
obstructed kidney, and these alterations can increase renal
vascular resistance, especially pre-glomerular resistance,
resulting in reduction of renal arterial blood flow. Pharma-
cological agents to antagonize endothelin or RAS system,
L-arginine to promote nitric oxide production, and a cal-
cium channel blocker (verapamil) which suppresses vaso-
constriction were shown to be effective in increasing renal
arterial blood flow in UUO kidney [16,18,19,22-24]. It
would be of interest to determine the roles of these path-
ways in reduction of 99mTc-MAG3 uptake in a mouse
UUO model using this imaging technique and genetically
manipulated mice or pharmacological treatments. Also,
further investigation would be required to determine thechanges of renal perfusion in a mouse UUO model using
a nuclear or MR imaging technique (e.g. dynamic suscep-
tibility contrast MRI) and evaluate the relation between
renal perfusion and the uptake of 99mTc-MAG3. Further,
it is of note that tracer deposition within renal pelvis is
highly limited in UUO mouse kidney, even at day 0 (3 hrs)
post surgery. Similar findings were also reported in pig
UUO kidney [25], These findings suggest that ureteral ob-
struction immediately reduces tubular function and the
radiotracer does not get into the renal pelvis. Further in-
vestigation would be required to determine the mechan-
ism of this. Last, compared to the obstructed kidney,
much less is known about the adaptive responses and
mechanisms in contralateral kidney. This issue should also
be addressed in future study.
Conclusions
This work assessed renal function in UUO mice by dy-
namic SPECT imaging with retro-orbital injection of
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of 99mTc-MAG3 is remarkably and rapidly reduced in
UUO kidneys, while the changes are minimal in contra-
lateral kidneys. The parametric analysis of TACs sug-
gested that renal perfusion as well as tubular uptake is
reduced in UUO kidneys. Given the fact that similar
changes are observed in 99mTc-MAG3 renogram in
human patients with renal obstruction [26,27], combin-
ation of this imaging technique with mouse UUO mod-
els should provide an effective assay for evaluating
treatment protocols of this disease or screening new
pharmacological agents as well as for elucidating patho-
physiological mechanisms of obstructive kidney disease.
Additional file
Additional file 1: Tantawy MN et al_Supplemental Figure S1: A
supplemental figure demonstrating the phases of 99mTc-MAG3
TACs and their determinants.
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